TX-SOFTSERVE
2.12.2021 13:07:03 CET | Business Wire | Press release
SoftServe , a leading digital authority and consulting company, has released its second bi-annual Sustainability Report . The report, prepared according to GRI Standards, highlights progress made against the company’s ongoing commitment to a sustainable business strategy, featuring key initiatives and achievements that positively impact society and the environment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211202005018/en/
“As a global organization, we must take responsibility towards our associates, customers, and communities,” said Chris Baker, CEO at SoftServe. “SoftServe is a people-centric company, focused on creating an inclusive workplace that supports our associates’ well-being, access to education, and innovation, which enables us to support sustainable development in our communities around the world.”
“In 2020 the world faced extraordinary new challenges that impacted each of us as individuals, and as a business,” said Taras Vervega, co-founder and board member at SoftServe. “It was another moment that revealed who we are as a company. The way SoftServe responded to the pandemic, the numerous solutions we have created to help our clients, and the massive response of our company and our people to help hospitals and local communities – all make me very proud of the company we’ve built.”
Diversity, Equality, and Inclusion
Since 2018, SoftServe has made significant progress towards gender equality, as the rate of women in managerial roles grew from 35% in 2018 to 49% in 2020. Additionally, as part of its inclusivity efforts, in 2020 the company launched its first learning course in accessibility testing for visually impaired people , and its graduates are now part of SoftServe’s accessibility testing team.
Advancing IT Education
Developing IT education is another focus of the company’s social initiatives. SoftServe’s IT Academy , an educational platform for students and graduates, enrolled 2,759 students and subsequently hired 1,368 graduates upon completion of its programs over the last two years. SoftServe currently maintains partnerships with 34 universities and tech schools in Ukraine, Bulgaria, and Poland, establishing new IT bachelor’s degree programs, launching tech labs, and hosting numerous educational events.
Empowering Communities
SoftServe’s approach to social responsibility includes empowering its people to give back to their communities. In 2020 SoftServe became strategic partner to UNICEF Ukraine. The parties cooperated on educational programs and initiatives in Ukraine to exchange knowledge and professional experience and worked together on several pro bono technology solutions.
Throughout 2020, SoftServe built a framework to engage associates in pro bono projects that address pressing social issues and created the company’s Open Tech crowdsourcing platform. Together with NGOs and governmental institutions, SoftServe contributed to a number of projects, including Ukraine’s National Volunteer Platform , created with UNICEF Ukraine, the Ukrainian Volunteer Service, and the Ministry of Youth and Sports of Ukraine. The Platform is an online portal that helps connect volunteers with opportunities around social assistance, education and science, culture, art, and more.
SoftServe also developed a COVID-19 triage chatbot for the Bulgarian government to provide citizens with critical information, answers to frequently asked questions, and healthcare contact information to help assess symptoms and navigate the next steps. Using advanced conversational AI, the triage chatbot quickly assesses users with a series of text or voice questions, eliminating staff burden and soothing patient fears. It is an omnichannel communication tool available on any smartphone, computer, or tablet, and can help to triage patients in under 30 seconds.
Other key social achievements include:
- 4 international awards for SoftServe’s corporate social responsibility and sustainability initiatives and projects
- 92 volunteer and charitable projects accomplished in 2019–2020
- 50+ events launched dedicated to emotional health and employee well-being
- 752 computers donated to educational establishments in 2019-2020
- 10,000+ trees planted in 2019–2020
- $882,500 contributed to projects implemented by SoftServe’s “Open Eyes” charity fund in 2019–2020
- 10+ tons of medical equipment funded via SoftServe & “Open Eyes” charity fund
About SoftServe
SoftServe is a digital authority that advises and provides at the cutting-edge of technology. We reveal, transform, accelerate, and optimize the way enterprises and software companies do business. With expertise across healthcare, retail, energy, financial services, software, and more, we implement end-to-end solutions to deliver the innovation, quality, and speed that our clients’ users expect.
SoftServe delivers open innovation - from generating compelling new ideas, to developing and implementing transformational products and services. Our work and client experience are built on a foundation of empathetic, human-focused experience design that ensures continuity from concept to release. We empower enterprises and software companies to (re)identify differentiation, accelerate solution development, and vigorously compete in today’s digital economy. No matter where you are in your journey.
Visit our website , blog , LinkedIn , Facebook , and Twitter pages.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211202005018/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom